Skip to main content
Article
Dipeptidyl peptidase 4 inhibitors and bullous pemphigoid − more evidence of a link: a report of three cases
British Journal of Diabetes (2020)
  • Amrita Randhawa, Department of Dermatology, #R##N#Queen Elizabeth University Hospital,#R##N#Glasgow
  • Donna Torley, Department of Dermatology, #R##N#Queen Elizabeth University Hospital,#R##N#Glasgow
  • Alastair Kerr, Department of Dermatology, #R##N#Queen Elizabeth University Hospital,#R##N#Glasgow
  • Grant Wylie, Department of Dermatology#R##N#Queen Elizabeth University Hospital#R##N#Glasgow
Publication Date
December 13, 2020
DOI
10.15277/BJD.2020.262
Citation Information
Amrita Randhawa, Donna Torley, Alastair Kerr and Grant Wylie. "Dipeptidyl peptidase 4 inhibitors and bullous pemphigoid − more evidence of a link: a report of three cases" British Journal of Diabetes Vol. 20 Iss. 2 (2020) p. 147 - 148
Available at: http://works.bepress.com/amrita-randhawa/2/